spacer
home > pmps > summer 2002 > options in materials for liquid-filled capsules
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Options in Materials for Liquid-Filled Capsules

This article describes the current status of some potential substitutes for gelatine two-piece capsules, with particular reference to their suitability for liquid products. Animal gelatine presents a number of issues, including technical, regulatory, commercial and consumer acceptability aspects. The use of possible substitutes - 'fish gelatine', starch and hydroxypropyl methylcellulose (HPMC) - is discussed. Particular reference is made to progress in the suitability of HPMC capsules for commercial manufacture (including filling and sealing). The article will also include relevant comment on their current regulatory status.

Hard (or 'two-piece') capsules have been used in medicines for many years, and are also being used in increasing quantities in nutraceuticals. The commercial manufacturing process for the capsule shell itself was first established for gelatine in 1913. It led to the development of major automatic machines which form the basis of current shell manufacture worldwide.

The raw material gelatine, however, is derived from animal material and has presented a wide range of issues (technical, regulatory, commercial, limits to consumer selection according to religious or dietary needs) and there have been many investigations and commercial efforts to identify possible substitutes (1). In recent years, safety concerns about transmissible spongiform encephalopathies (TSE) and other animal diseases have increased the need for such materials. This paper describes the current status of a) gelatine derived from fish, b) starch and c) hydroxypropyl methylcellulose (HPMC) as potential substitutes for current gelatine two-piece capsules, including assessment of their suitability for liquid products.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By William Bowtle, Technical Director at MW Encap Ltd, UK William Bowtle, Technical Director at MW Encap, is one of the leading scientists in liquid filling of hard gelatine capsules. After graduating with a first class honours degree in Pharmacy from Strathclyde University in Glasgow, Scotland, he continued his research work while assuming the post of Lecturer in Pharmaceutics, and was awarded a Pfizer Research Prize.
He later moved into industry and worked for 13 years with Eli Lilly, where, as Head of Pharmaceutical Development, he was responsible for the development of a range of oral and parenteral products for international markets. During that time he developed the 'semi-solid matrix' capsule technology. In his position as Technical Director at MW Encap, Bill is responsible for the co-ordination of all technical aspects of new products.

spacer
William Bowtle
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera acquires Insight Product Development to strengthen its capabilities

“Every day at Nemera, we work to improve the lives of millions of patients worldwide by designing, developing and manufacturing innovative drug delivery devices. Our vision as a team is to become the most patient-centric drug delivery device company in the industry. We partner closely with our customers to deliver innovative and high quality devices, to ensure that patients will receive the best product and service possible” Marc Hämel, CEO
More info >>

White Papers

Bringing more control to temperature-sensitive logistics

UPS Supply Chain Solutions

By 2016, world sales of cold-chain drugs and biologics such as vaccines and blood plasma products will near $240 billion1. The increase has led to a surge in discussion about how to protect these products throughout the transportation logistics cycle. Industry experts are recommending that the term “cold chain” be eliminated from rules, guidance and best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room temperature (CRT). This white paper focuses on the initial steps required to establish a temperature-sensitive supply chain.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement